Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.03
-0.12 (-2.33%)
At close: Aug 18, 2025, 3:59 PM
5.07
0.90%
After-hours: Aug 18, 2025, 04:10 PM EDT

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics reported an annual revenue of $7.69M, reflecting a -2.36% growth. For the quarter ending March 31, 2025, Bolt Biotherapeutics generated $1.22M in revenue.
Revenue (ttm)
7.69M
Revenue Growth
-2.36%
Price / Sales Ratio
53.13
Revenue / Employee
147.88K
Employees
52
Market Cap
9.63M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 7.69M -2.36%
Dec 31, 2023 7.88M +37.48%
Dec 31, 2022 5.73M +354.68%
Dec 31, 2021 1.26M +445.45%
Dec 31, 2020 231K +7.44%
Dec 31, 2019 215K +Infinity%
Dec 31, 2018 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.